EDGAR Filing Documents for 0001213900-21-008478

Form 8-K - Current report:

SEC Accession No. 0001213900-21-008478

Filing Date

2021-02-11

Accepted

2021-02-11 16:30:42

Documents

Period of Report

2021-02-05

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea135023-8k_geminitherap.htm	8-K	179294
2	MERGER AGREEMENT, DATED AS OF OCTOBER 15, 2020, BY AND AMONG GEMINI THERAPEUTICS	ea135023ex2-1_gemini.htm	EX-2.1	762085
3	AMENDED AND RESTATED ARTICLES OF CERTIFICATE OF INCORPORATION GEMINI THERAPEUTIC	ea135023ex3-1_gemini.htm	EX-3.1	42939
4	AMENDED AND RESTATED BY-LAWS OF GEMINI THERAPEUTICS, INC	ea135023ex3-2_gemini.htm	EX-3.2	118517
5	FORM OF SPECIMEN COMMON STOCK CERTIFICATE	ea135023ex4-1_gemini.htm	EX-4.1	11086
6	VOTING AGREEMENT, DATED FEBRUARY 5, 2021, BY AND AMONG GEMINI THERAPEUTICS, INC.	ea135023ex10-2_gemini.htm	EX-10.2	45920
7	LOCKUP AGREEMENT, DATED FEBRUARY 5, 2021, BY AND AMONG GEMINI THERAPEUTICS, INC.	ea135023ex10-3_gemini.htm	EX-10.3	100952
8	GEMINI 2021 STOCK OPTION AND INCENTIVE PLAN	ea135023ex10-4_gemini.htm	EX-10.4	99083
9	FORMS OF AWARD AGREEMENTS UNDER THE GEMINI 2021 STOCK OPTION AND INCENTIVE PLAN	ea135023ex10-5_gemini.htm	EX-10.5	122565
10	FORM OF INDEMNIFICATION AGREEMENT FOR DIRECTORS OF GEMINI THERAPEUTICS, INC	ea135023ex10-6_gemini.htm	EX-10.6	75272
11	FORM OF INDEMNIFICATION AGREEMENT FOR EXECUTIVE OFFICERS OF GEMINI THERAPEUTICS,	ea135023ex10-7_gemini.htm	EX-10.7	70988
12	FORM OF SUBSCRIPTION AGREEMENT	ea135023ex10-8_gemini.htm	EX-10.8	114555
13	EMPLOYMENT AGREEMENT, DATED JANUARY 21, 2021, BY AND BETWEEN GEMINI THERAPEUTICS	ea135023ex10-9_gemini.htm	EX-10.9	116005
14	EMPLOYMENT AGREEMENT, DATED DECEMBER 24, 2020, BY AND BETWEEN GEMINI THERAPEUTIC	ea135023ex10-10_gemini.htm	EX-10.10	119520
15	EMPLOYMENT AGREEMENT, DATED JANUARY 22, 2021, BY AND BETWEEN GEMINI THERAPEUTICS	ea135023ex10-11_gemini.htm	EX-10.11	108215
16	WITHUM'S LETTER TO THE SECURITIES AND EXCHANGE COMMISSION, DATED FEBRUARY 11, 20	ea135023ex16-1_gemini.htm	EX-16.1	2619
17	LIST OF SUBSIDIARIES	ea135023ex21-1_gemini.htm	EX-21.1	2301
18	UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION	ea135023ex99-1_gemini.htm	EX-99.1	170700
19	PRESS RELEASE	ea135023ex99-2_gemini.htm	EX-99.2	20205
20	GRAPHIC	image_001.jpg	GRAPHIC	57284
21	GRAPHIC	ex99-2_001.jpg	GRAPHIC	4145
	Complete submission text file	0001213900-21-008478.txt		2369503

Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139

Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400

Gemini Therapeutics, Inc. /DE (Filer) CIK: 0001816736 (see all company filings)